Cargando…

Duration of basic and attenuated-psychotic symptoms in individuals at clinical high risk for psychosis: pattern of symptom onset and effects of duration on functioning and cognition

INTRODUCTION: Duration of risk symptoms (DUR) in people at clinical high risk for psychosis (CHR-P) has been related to poorer clinical outcomes, such as reduced functioning, but it is currently unclear how different symptoms emerge as well as their link with cognitive deficits. To address these que...

Descripción completa

Detalles Bibliográficos
Autores principales:	Staines, Lorna, Gajwani, Ruchika, Gross, Joachim, Gumley, Andrew I., Lawrie, Stephen M., Schwannauer, Matthias, Schultze-Lutter, Frauke, Uhlhaas, Peter J.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2021
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8265048/ https://www.ncbi.nlm.nih.gov/pubmed/34233651 http://dx.doi.org/10.1186/s12888-021-03267-2

Ejemplares similares

S64. COGNITIVE IMPAIRMENTS AND PREDICTION OF FUNCTIONAL OUTCOME IN INDIVIDUALS AT CLINICAL HIGH-RISK FOR PSYCHOSIS
por: Haining, Kate, et al.
Publicado: (2020)

Grey-matter abnormalities in clinical high-risk participants for psychosis
por: Zikidi, Katia, et al.
Publicado: (2020)

Altered Autonomic Function in Individuals at Clinical High Risk for Psychosis
por: Kocsis, Anna, et al.
Publicado: (2020)

Prevalence and predictors of suicidality and non‐suicidal self‐harm among individuals at clinical high‐risk for psychosis: Results from a community‐recruited sample
por: Haining, Kate, et al.
Publicado: (2020)

Hippocampal structural alterations in early-stage psychosis: Specificity and relationship to clinical outcomes
por: Brunner, Gina, et al.
Publicado: (2022)

Association of Magnetoencephalographically Measured High-Frequency Oscillations in Visual Cortex With Circuit Dysfunctions in Local and Large-scale Networks During Emerging Psychosis
por: Grent-‘t-Jong, Tineke, et al.
Publicado: (2020)

MR-Spectroscopy of GABA and Glutamate/Glutamine Concentrations in Auditory Cortex in Clinical High-Risk for Psychosis Individuals
por: Grent-’t-Jong, Tineke, et al.
Publicado: (2022)

Characterising cognitive heterogeneity in individuals at clinical high-risk for psychosis: a cluster analysis with clinical and functional outcome prediction
por: Haining, Kate, et al.
Publicado: (2021)

Using Online Screening in the General Population to Detect Participants at Clinical High-Risk for Psychosis
por: McDonald, Mhairi, et al.
Publicado: (2019)

S214. USING ONLINE-SCREENING TO DETECT PARTICIPANTS AT CLINICAL HIGH-RISK FOR PSYCHOSIS
por: McDonald, Mhairi, et al.
Publicado: (2018)

Thalamo-cortical circuits during sensory attenuation in emerging psychosis: a combined magnetoencephalography and dynamic causal modelling study
por: Hua, Lingling, et al.
Publicado: (2023)

F153. NEUROMAGNETIC MISMATCH NEGATIVITY IN CLINICAL HIGH RISK AND FIRST-EPISODE PSYCHOSIS INDIVIDUALS
por: Mikanmaa, Emmi, et al.
Publicado: (2018)

The Youth Mental Health Risk and Resilience Study (YouR-Study)
por: Uhlhaas, Peter J., et al.
Publicado: (2017)

F159. NEUROMAGNETIC 40 HZ AUDITORY STEADY STATE RESPONSES AND AUDITORY CORTICAL GABA AND GLX IN CLINICAL HIGH RISK AND FIRST EPISODE OF PSYCHOSIS INDIVIDUALS
por: Thuné, Hanna, et al.
Publicado: (2018)

Revisiting the Basic Symptom Concept: Toward Translating Risk Symptoms for Psychosis into Neurobiological Targets
por: Schultze-Lutter, Frauke, et al.
Publicado: (2016)

Resting-state gamma-band power alterations in schizophrenia reveal E/I-balance abnormalities across illness-stages
por: Grent-'t-Jong, Tineke, et al.
Publicado: (2018)

Basic symptoms in offspring of parents with mood and psychotic disorders
por: Zwicker, Alyson, et al.
Publicado: (2019)

Age effects on basic symptoms in the community: A route to gain new insight into the neurodevelopment of psychosis?
por: Schultze-Lutter, Frauke, et al.
Publicado: (2018)

S155. SENSORY ATTENUATION DURING AUDITORY PROCESSING IN PARTICIPANTS AT CLINICAL-HIGH RISK FOR PSYCHOSIS: EVIDENCE FROM MAGNETOENCEPHALOGRAPHY
por: Hua, Lingling, et al.
Publicado: (2018)

Sleep duration and psychotic experiences in patients at risk of psychosis: A secondary analysis of the EDIE-2 trial
por: Reeve, S., et al.
Publicado: (2019)

Psychosis and Schizophrenia-Spectrum Personality Disorders Require Early Detection on Different Symptom Dimensions
por: Schultze-Lutter, Frauke, et al.
Publicado: (2019)

Prevalence and clinical relevance of interview-assessed psychosis-risk symptoms in the young adult community
por: Schultze-Lutter, Frauke, et al.
Publicado: (2018)

S42. KETAMINE DYSREGULATES TASK-RELATED NEURAL OSCILLATIONS IN THALAMO-CORTICAL CIRCUITS: IMPLICATIONS FOR PATHOPHYSIOLOGICAL THEORIES OF VISUAL-PERCEPTUAL DEFICITS IN SCHIZOPHRENIA
por: Grent-’t-Jong, Tineke, et al.
Publicado: (2018)

T93. PERSONALITY TRAITS AND PSYCHOTIC SYMPTOMS IN RECENT ONSET OF PSYCHOSIS PATIENTS
por: Sevilla-Llewellyn-Jones, Julia, et al.
Publicado: (2018)

Reduced duration mismatch negativity in adolescents with psychotic symptoms: further evidence for mismatch negativity as a possible biomarker for vulnerability to psychosis
por: Murphy, Jennifer R, et al.
Publicado: (2013)

Acute ketamine dysregulates task-related gamma-band oscillations in thalamo-cortical circuits in schizophrenia
por: Grent-‘t-Jong, Tineke, et al.
Publicado: (2018)

The role of mentalizing in the relationship between schizotypal personality traits and state signs of psychosis risk captured by cognitive and perceptive basic symptoms
por: Salaminios, George, et al.
Publicado: (2023)

Clinical Predictors of Duration of Untreated Psychosis: Exploring Psychosocial and Clinical Predictors of Duration of Untreated Psychosis in First-Episode Psychotic Patients in Mzuzu, Malawi
por: Myaba, Japhet, et al.
Publicado: (2021)

S128. CORRELATION OF DURATION OF UNTREATED PSYCHOSIS WITH TREATMENT RESPONSE ON THE SYMPTOM DIMENSIONS OF SCHIZOPHRENIA
por: Elias, Beatriz Yukie, et al.
Publicado: (2018)

No age effect in the prevalence and clinical significance of ultra-high risk symptoms and criteria for psychosis in 22q11 deletion syndrome: Confirmation of the genetically driven risk for psychosis?
por: Armando, Marco, et al.
Publicado: (2017)

F186. TAPETUM ABNORMALITIES IN FIRST-EPISODE PSYCHOSIS AND RELATIONSHIP TO SYMPTOM SEVERITY AND DURATION OF UNTREATED PSYCHOSIS
por: Lee, Sun Woo, et al.
Publicado: (2018)

Recruiting and exploring vulnerabilities among young people at risk, or in the early stages of serious mental illness (borderline personality disorder and first episode psychosis)
por: Gajwani, Ruchika, et al.
Publicado: (2022)

Symptom Dimensions of the Psychotic Symptom Rating Scales in Psychosis: A Multisite Study
por: Woodward, Todd S., et al.
Publicado: (2014)

The effect of duration of untreated psychosis and treatment delay on the outcomes of prolonged early intervention in psychotic disorders
por: Albert, Nikolai, et al.
Publicado: (2017)

Routes to psychotic symptoms: Trauma, anxiety and psychosis-like experiences
por: Freeman, Daniel, et al.
Publicado: (2009)

O11.8. PREVALENCE AND PREDICTORS OF INTERVIEW-ASSESSED CLINICAL HIGH-RISK SYMPTOMS IN THE GENERAL POPULATION
por: Schultze-Lutter, Frauke, et al.
Publicado: (2018)

A Chinese version of the Psychotic Symptom Rating Scales: psychometric properties in recent-onset and chronic psychosis
por: Chien, Wai-Tong, et al.
Publicado: (2017)

Association between duration of Untreated Psychosis and severer symptoms and poorer quality of life: study in First-Episode Psychosis patients
por: Pires, A. C. M., et al.
Publicado: (2023)

Symptom Dimensions as Predictors of Clinical Outcome, Duration of Hospitalization, and Aggressive Behaviours in Acutely Hospitalized Patients with Psychotic Exacerbation
por: Colasanti, Alessandro, et al.
Publicado: (2010)

Relationship Between Cognitive and Clinical Insight at Different Durations of Untreated Attenuated Psychotic Symptoms in High-Risk Individuals
por: Xu, LiHua, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_5kp88kv4e5s5h6hnmmb27l935p